Prime Medicine, Inc. (PRME) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -42.71M | -37.26M | -35.04M | -41.41M | -48.86M | 16.25M | -25.91M | -45.49M | -67.71M | -43.86M | -39.17M | -40.82M |
| Operating CF Margin % | -4989.49% | -4445.82% | -2860.33% | -3714.08% | -3360.18% | 744.16% | -12398.09% | - | -11456.35% | - | - | - |
| Operating CF Growth % | 12.58% | -329.34% | -35.22% | 8.97% | 27.84% | 137.03% | 33.84% | -11.44% | -62.91% | -42.82% | -30.13% | -101.85% |
| Net Income | -49.12M | -46.08M | -50.58M | -52.59M | -51.89M | -42.28M | -52.52M | -55.33M | -45.76M | -65.64M | -50.71M | -42.38M |
| Depreciation & Amortization | 1.86M | 514K | 1.88M | 1.45M | 1.54M | 1.72M | 1.56M | 1.54M | 1.31M | 1.25M | 1.24M | 4.59M |
| Stock-Based Compensation | 0 | 4.51M | 12.75M | 6.33M | 5.68M | 5.94M | 6.83M | 0 | 5.21M | 4.43M | 4.22M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -134K | 134K | -4.64M | -108K | 31K |
| Other Non-Cash Items | 7.06M | 2.64M | 306K | 2.85M | 3.47M | 2M | 14.64M | 13.18M | 1.51M | 6.3M | 3.8M | 2.53M |
| Working Capital Changes | -2.5M | 1.16M | 609K | 548K | -7.65M | 48.86M | 3.58M | -4.75M | -30.11M | 14.45M | 2.4M | -5.59M |
| Change in Receivables | 0 | 0 | 120K | -103K | -17K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 3.55M | -581K | 3.04M | -3.35M | 1.88M | 2.46M | 1.51M | -3.35M | -5.88M | 2.28M | 5.76M | 1.61M |
| Cash from Investing | 43.39M | 28.33M | -92.12M | 2.77M | -47.74M | 48.25M | 50.34M | 6.89M | -37.03M | 41.28M | -37.77M | 27.86M |
| Capital Expenditures | -214K | -290K | -247K | -1.57M | -2.42M | -1.79M | -1.28M | -1.9M | -2.32M | -1.84M | -2.91M | -1.98M |
| CapEx % of Revenue | 25% | 34.61% | 20.16% | 140.99% | 166.58% | 82.04% | 611% | - | 393.23% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -43.13K | 34.86K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 276K | 724K | 0 | 0 | 43.13K | -34.86K | -170K |
| Cash from Financing | 393K | 562K | 144.75M | 197K | 6M | 1K | 38.51M | 35K | 157.33M | 194K | 318K | 75K |
| Debt Issued (Net) | 0 | -6M | 0 | 0 | 6M | 0 | 0 | 0 | 6M | 0 | 0 | 0 |
| Equity Issued (Net) | 393K | -138.95M | 138.75M | 197K | 0 | 1K | 38.08M | 151.33M | 132.06M | 194K | 318K | 75K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 145.51M | 6M | 0 | 0 | 0 | 432K | -151.29M | 19.27M | 0 | 0 | 0 |
| Net Change in Cash | 1.07M | -8.36M | 17.59M | -38.44M | -90.6M | 64.5M | 62.94M | -38.56M | 52.59M | -2.38M | -76.62M | -12.88M |
| Free Cash Flow | -42.92M | -37.55M | -35.29M | -42.98M | -51.28M | 14.45M | -27.19M | -47.39M | -70.03M | -45.7M | -42.08M | -42.8M |
| FCF Margin % | -5014.49% | -4480.43% | -2880.49% | -3855.07% | -3526.75% | 662.12% | -13009.09% | - | -11849.58% | - | - | - |
| FCF Growth % | 16.29% | -359.76% | -29.78% | 9.3% | 26.78% | 131.63% | 35.38% | -10.74% | -60.77% | -28.65% | -20.6% | -71.02% |
| FCF per Share | -0.24 | -0.25 | -0.22 | -0.33 | -0.39 | 0.12 | -0.23 | -0.40 | -0.67 | -0.47 | -0.46 | -0.47 |
| FCF Conversion (FCF/Net Income) | 0.87x | 0.81x | 0.69x | 0.79x | 0.94x | -0.38x | 0.49x | 0.82x | 1.48x | 0.67x | 0.77x | 0.96x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |